Kuenhi Tsai, PhD

Kuenhi Tsai has extensive pharmaceutical and biometrics experiences providing for late-stage clinical development, early-stage clinical pharmacology, post-market research, and pre-clinical discovery with more than 23 years working at major, small, and CRO pharmaceutical companies. He was involved in life-cycle management discussion for multiple companies. He developed innovative designs for both early and late phase studies and led Modeling and Simulation projects, data analysis for NDA filing. He was a director of Merck and represented the company in multiple pharma working groups. He received his Ph.D. in dual majors, Biomathematics and Statistics, from North Carolina State University, M.S. from University of Montana.